These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35458556)

  • 1. Development of Robust Varicella Zoster Virus Luciferase Reporter Viruses for In Vivo Monitoring of Virus Growth and Its Antiviral Inhibition in Culture, Skin, and Humanized Mice.
    Lloyd MG; Yee MB; Flot JS; Liu D; Geiler BW; Kinchington PR; Moffat JF
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Human Skin Tissue Model To Study Varicella-Zoster Virus and Human Cytomegalovirus.
    Lloyd MG; Smith NA; Tighe M; Travis KL; Liu D; Upadhyaya PK; Kinchington PR; Chan GC; Moffat JF
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32878893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
    Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
    Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system.
    Zhang Z; Rowe J; Wang W; Sommer M; Arvin A; Moffat J; Zhu H
    J Virol; 2007 Sep; 81(17):9024-33. PubMed ID: 17581997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella-Zoster Virus Activates CREB, and Inhibition of the pCREB-p300/CBP Interaction Inhibits Viral Replication In Vitro and Skin Pathogenesis In Vivo.
    François S; Sen N; Mitton B; Xiao X; Sakamoto KM; Arvin A
    J Virol; 2016 Oct; 90(19):8686-97. PubMed ID: 27440893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism.
    De C; Liu D; Zheng B; Singh US; Chavre S; White C; Arnold RD; Hagen FK; Chu CK; Moffat JF
    Antiviral Res; 2014 Oct; 110():10-9. PubMed ID: 25051026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-Associated Differences in Infection of Human Skin in the SCID Mouse Model of Varicella-Zoster Virus Pathogenesis.
    Zerboni L; Sung P; Lee G; Arvin A
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compounds that target host cell proteins prevent varicella-zoster virus replication in culture, ex vivo, and in SCID-Hu mice.
    Rowe J; Greenblatt RJ; Liu D; Moffat JF
    Antiviral Res; 2010 Jun; 86(3):276-85. PubMed ID: 20307580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of varicella zoster virus pathogenesis.
    Zerboni L; Sen N; Oliver SL; Arvin AM
    Nat Rev Microbiol; 2014 Mar; 12(3):197-210. PubMed ID: 24509782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts.
    Oliver SL; Zerboni L; Sommer M; Rajamani J; Arvin AM
    J Virol Methods; 2008 Dec; 154(1-2):182-93. PubMed ID: 18761377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of varicella-zoster virus ORF47 protein kinase and IE62 protein binding domains and their contributions to replication in human skin xenografts in the SCID-hu mouse.
    Besser J; Sommer MH; Zerboni L; Bagowski CP; Ito H; Moffat J; Ku CC; Arvin AM
    J Virol; 2003 May; 77(10):5964-74. PubMed ID: 12719588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of varicella-zoster virus neurotropism and neurovirulence using SCID mouse-human DRG xenografts.
    Zerboni L; Arvin A
    J Neurovirol; 2011 Dec; 17(6):570-7. PubMed ID: 22161683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis.
    Sen N; Che X; Rajamani J; Zerboni L; Sung P; Ptacek J; Arvin AM
    Proc Natl Acad Sci U S A; 2012 Jan; 109(2):600-5. PubMed ID: 22190485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella-zoster virus neurotropism in SCID mouse-human dorsal root ganglia xenografts.
    Zerboni L; Reichelt M; Arvin A
    Curr Top Microbiol Immunol; 2010; 342():255-76. PubMed ID: 20225014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of the varicella-zoster virus ORF62/63 intergenic region.
    Jones JO; Sommer M; Stamatis S; Arvin AM
    J Virol; 2006 Mar; 80(6):3116-21. PubMed ID: 16501125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Sp1/Sp3 site in the downstream region of varicella-zoster virus (VZV) oriS influences origin-dependent DNA replication and flanking gene transcription and is important for VZV replication in vitro and in human skin.
    Khalil MI; Robinson M; Sommer M; Arvin A; Hay J; Ruyechan WT
    J Virol; 2012 Dec; 86(23):13070-80. PubMed ID: 22933283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection.
    Berarducci B; Rajamani J; Zerboni L; Che X; Sommer M; Arvin AM
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):282-7. PubMed ID: 19966293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo.
    Oliver SL; Sommer M; Zerboni L; Rajamani J; Grose C; Arvin AM
    J Virol; 2009 Aug; 83(15):7495-506. PubMed ID: 19474103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varicella-zoster virus infection of human dorsal root ganglia in vivo.
    Zerboni L; Ku CC; Jones CD; Zehnder JL; Arvin AM
    Proc Natl Acad Sci U S A; 2005 May; 102(18):6490-5. PubMed ID: 15851670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and therapeutic aspects of varicella-zoster virus infection.
    Quinlivan M; Breuer J
    Expert Rev Mol Med; 2005 Aug; 7(15):1-24. PubMed ID: 16098235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.